Fundraising FoxBiotech Startups
10,871 companies tagged Biotech, with their investors and founders.
Strella makes sensors that monitor ethylene, the gas that drives ripening in fruits and vegetables, to track produce freshness across the supply chain. Its technology is used to help manage produce such as apples in the U.S. food supply.
11 investors
TetraScience operates an R&D Data Cloud for life sciences, giving pharma and biotech organizations centralized, harmonized, and actionable scientific data to support digital lab transformation. It targets scientists at global pharmaceutical and biotech companies.
11 investors
Unlearn develops AI-powered digital twins and data analytics tools to optimize clinical trial design and execution for pharmaceutical companies. The company aims to accelerate drug development and bring treatments to patients faster through precision-driven study design.
11 investors
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing. The company serves pharmaceutical partners and research institutions developing new medicines.
11 investors
Volumetric builds living multicellular human tissues using 3D bioprinting technology that creates complex blood vessel networks, primarily to produce patient-specific tissues for drug safety and efficacy testing, basic biology research, and screening. The company aims longer term to produce functional tissue and organ replacements for damaged vital organs such as the lung, liver, pancreas, kidney, and heart.
11 investors
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields. Its biodegradable materials target industries including personal hygiene, fashion and apparel, and coatings, aiming to reduce reliance on fossil-based sources and microplastics.
11 investors
1849 bio engineers microorganisms to make metal extraction from low-grade copper and gold ores economically viable for mining operations. The company applies advanced bioengineering techniques to develop microbes capable of processing ore types that existing biomining processes cannot handle, targeting the hundreds of billions of dollars in copper currently considered uneconomical to extract.
10 investors
54gene is an African genomics company offering research, services, and development focused on including under-represented African genomic data in medical research. It aims to support medical breakthroughs and new healthcare solutions, with a focus on Africans and the global population.
10 investors
Acronis provides an integrated cyber protection platform for managed service providers (MSPs) that combines operations management, cybersecurity, and data protection capabilities to reduce costs and security risks across client workloads.
10 investors
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases. The company combines next-generation RNA therapeutics, brain delivery technologies, and biomarker-guided precision medicine to silence disease-causing genes in the brain.
10 investors
Alumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
10 investors
Antiverse is a techbio company that uses machine learning and cell line engineering to design de novo antibody therapeutics against difficult targets such as G-protein coupled receptors and ion channels. It works with pharmaceutical companies and develops its own internal antibody pipeline across multiple indications.
10 investors
Apheris provides a platform enabling large global life sciences organizations to collaborate on sensitive, proprietary data and jointly train machine learning models on distributed datasets while maintaining privacy across teams, borders, and organizations.
10 investors
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases. The company combines drug development expertise with cellular biology to create new therapeutic approaches.
10 investors
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers. Its pipeline centers on its lead candidate firmonertinib (formerly furmonertinib) and novel oncology therapeutics such as next-generation antibody drug conjugates.
10 investors
Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.
10 investors
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies. The company operates in the biotech and respiratory drug development space.
10 investors
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions. The company was founded in 2025 following a strategic combination of atai Life Sciences and Beckley Psytech.
10 investors
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.
10 investors
Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders. It focuses on drug development for patients with these conditions.
10 investors
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders. The company serves patients with conditions driven by cellular aging and senescence.
10 investors
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
10 investors
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells. The company focuses on oncology diagnostics and therapeutics for cancer patients.
10 investors
Endolith develops biological intelligence technology for mineral recovery, using microbiology and AI to extract critical minerals sustainably. The company serves mining operations and the clean energy supply chain.
10 investors